PORTLAND, OREGON, UNITED STATES, August 1, 2024 /EINPresswire.com/ -- According to the report, the global cluster headache industry generated $356.00 million in 2021, and is estimated to reach $522.98 million by 2031, witnessing a CAGR of 3.9% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios

Download Free Sample of the Report- https://www.alliedmarketresearch.com/request-sample/14812

Drivers, Restraints, and Opportunities-

Development of novel therapeutics for treatment of cluster headache, awareness activities related to headache disorders and increase in R&D activities for development of novel drugs are the factors driving the growth of the global cluster headache market. On the other hand, side effects of the medications impede the growth to some extent. However, rise in investment by the major key players is expected to create lucrative opportunities in the industry.

Impact of Covid-19 on Cluster Headache Market-

Rise in number of people suffering from headache disorders such as cluster headache, and COVID-19 vaccinations triggered new cluster episodes in patients with cluster headache, during the pandemic had a moderately positive impact on the global cluster headache market.
However, as the global situation has recovered, the market has now got back on track.
Procure Complete Report (232 Pages PDF with Insights, Charts, Tables, and Figures)
https://tinyurl.com/4rn5wn2e

The episodic segment to rule the roost-

By type, the episodic segment was highest revenue contributor in 2021, garnering around three-fourth of the global cluster headache market revenue, and is projected to maintain its dominance by 2031. The same segment would also showcase the fastest CAGR of 4.1% during the forecast period. Various factors such as rise in number of people suffering from episodic attack and rise in regulatory approval of drugs indicated for episodic cluster headaches drives the segment growth.

The triptans segment garnered the major share in 2021-

By drug class, triptans segment was highest revenue contributor in 2021, generating more than two-fifth of the global cluster headache market revenue owing to first line treatment for cluster headache. The others segment showcased the fastest CAGR of 4.4% throughout the forecast period. This is attributed to rise in regulatory approvals of novel drugs and usage in treatment of cluster headache.

The drug stores and retail pharmacies segment accounted for major share in 2021-

By distribution channel, the drug stores and retail pharmacies segment accounted for the largest share in 2021, generating more than half of the global cluster headache market revenue owing to accessibility of retail pharmacies everywhere and large chain of distribution networks. The online providers segment would register the fastest CAGR of 5.1% during the forecast period. This is due to rise in popularity of online pharmacy and number of users preferring online pharmacies.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/14812

North America garnered the major share in 2021-

By region, North America held the major share in 2021, garnering more thantwo fifth of the global cluster headache market revenue owing to rise in prevalence of cluster headache cases and increase in number of key players offering novel therapeutics. However, Asia-Pacific would showcase the fastest CAGR of 4.8% from 2022 to 2031 owing to increase in number of headache disorders, rise in awareness campaign, and surge in investments for development of effective drugs for treating cluster headache.

Leading Market Players-

Arrotex Australia Group
AstraZeneca
Dr. Reddy's Laboratories Ltd.
Eli Lilly and Company
Fresenius SE & Co. KGaA
GlaxoSmithKline plc
Novartis AG
Pfizer Inc
Sun Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd

The report analyzes these key players in the global cluster headache market. These players have adopted various strategies such as product approval and merger to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, developments, and product portfolios of every market player.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.